Fazadinium bromide
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Fazadinium bromide
- DrugBank Accession Number
- DB13745
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 604.35
Monoisotopic: 602.042921 - Chemical Formula
- C28H24Br2N6
- Synonyms
- Fazadinium bromide
- External IDs
- AH 8165D
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your software1,2-Benzodiazepine The risk or severity of CNS depression can be increased when 1,2-Benzodiazepine is combined with Fazadinium bromide. Acetazolamide The risk or severity of CNS depression can be increased when Acetazolamide is combined with Fazadinium bromide. Acetophenazine The risk or severity of CNS depression can be increased when Acetophenazine is combined with Fazadinium bromide. Agomelatine The risk or severity of CNS depression can be increased when Agomelatine is combined with Fazadinium bromide. Alfentanil The risk or severity of CNS depression can be increased when Alfentanil is combined with Fazadinium bromide. - Food Interactions
- Not Available
Categories
- ATC Codes
- M03AC08 — Fazadinium bromide
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as phenylimidazoles. These are polycyclic aromatic compounds containing a benzene ring linked to an imidazole ring through a CC or CN bond.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Azoles
- Sub Class
- Imidazoles
- Direct Parent
- Phenylimidazoles
- Alternative Parents
- Imidazopyridines / Imidazo[1,2-a]pyridines / Pyridinium derivatives / N-substituted imidazoles / Benzene and substituted derivatives / Heteroaromatic compounds / Azacyclic compounds / Organonitrogen compounds / Organic bromide salts / Hydrocarbon derivatives show 1 more
- Substituents
- 4-phenylimidazole / 5-phenylimidazole / Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Heteroaromatic compound / Hydrocarbon derivative / Imidazo[1,2-a]pyridine / Imidazopyridine / Monocyclic benzene moiety show 8 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 8WV5538LFK
- CAS number
- 49564-56-9
- InChI Key
- LBOZSXSPRGACHC-NFOZGECASA-L
- InChI
- InChI=1S/C28H24N6.2BrH/c1-21-27(23-13-5-3-6-14-23)33(25-17-9-11-19-31(21)25)29-30-34-26-18-10-12-20-32(26)22(2)28(34)24-15-7-4-8-16-24;;/h3-20H,1-2H3;2*1H/q+2;;/p-2/b30-29+;;
- IUPAC Name
- 3-methyl-1-[(E)-2-{3-methyl-2-phenyl-1H-4lambda5-imidazo[1,2-a]pyridin-4-ylium-1-yl}diazen-1-yl]-2-phenyl-1H-4lambda5-imidazo[1,2-a]pyridin-4-ylium dibromide
- SMILES
- [Br-].[Br-].CC1=C(N(\N=N\N2C3=CC=CC=[N+]3C(C)=C2C2=CC=CC=C2)C2=CC=CC=[N+]12)C1=CC=CC=C1
References
- General References
- Not Available
- External Links
- ChemSpider
- 4882031
- ChEMBL
- CHEMBL1697835
- Wikipedia
- Fazadinium_bromide
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.00575 mg/mL ALOGPS logP 0.96 ALOGPS logP -0.3 Chemaxon logS -5 ALOGPS pKa (Strongest Basic) -0.091 Chemaxon Physiological Charge 2 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 42.78 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 142.88 m3·mol-1 Chemaxon Polarizability 49.76 Å3 Chemaxon Number of Rings 6 Chemaxon Bioavailability 1 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-001i-0920000000-2c4f69445b1005b9b023 - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 223.9009198 predictedDarkChem Lite v0.1.0 [M-H]- 193.95705 predictedDeepCCS 1.0 (2019) [M+H]+ 223.3743198 predictedDarkChem Lite v0.1.0 [M+H]+ 196.28072 predictedDeepCCS 1.0 (2019) [M+Na]+ 223.9376198 predictedDarkChem Lite v0.1.0 [M+Na]+ 202.0717 predictedDeepCCS 1.0 (2019)
Drug created at June 23, 2017 20:47 / Updated at February 21, 2021 18:54